However, the information available from the studies included in our analysis was limited, undermining our examination of the underlying mechanisms of potential PD biomarkers and their correlations with other clinical parameters (e.g., disease duration, sleep disturbance, and PD-related genes, such as LRRK2, SNCA, and GBA). This evidence concerns the gene GBA1 and Parkinson disease.